Selective in vitro cytotoxic effect of human cancer cells by Bluetongue virus-10

References

• Wechsler SJ, Mcholland LE. Susceptibilities of 14 cell lines to bluetongue virus infection. J Clin Microbiol 1988; 26: 2324–7
   PubMed Web of Science ®Google Scholar
• Hassan S, Roy P. Expression and functional characterization of bluetongue virus VP2 protein: Role in cell entry. J Virol 1999; 73: 9832–42
   PubMed Web of Science ®Google Scholar
• Mertens PPC, Diprose J. The bluetongue virus core: A nano-scale transcription machine. Virus Res 2004; 101: 29–43
   PubMed Web of Science ®Google Scholar
• Dong CY, Chen DE, Chen X, Cao ZH, Duan JR, Liu YH. Isolation of bluetongue virus strain HbC and its biological characters. The Clinic Medicine Research Beijing. Chinese Population Publishing House, Beijing 1998; 180–182
   Google Scholar
• Chen X, Yan YF, Dong CY, Chen BP, Tu P, Wang FJ. The characteristics of the propagation, purification and serology of bluetongue virus HbC Strain. Acta Acad Med HuBei 1999; 20: 179–91
   Google Scholar
• Liang K, Dong CY, Zhang WY, Hu J, Chen J. The infectivity of bluetongue virus strain HbC3 to MA782 cell. Virologica Sinica 2006; 21: 168–71
   Google Scholar
• Xiao AT, Dong CY, Li JK-K, Chen DE, Liu J, Zhang WY. Studies on the infectivity of bluetongue virus strain HbC3 to several human and animal tumor cells. Virologica Sinica 2004; 19: 349–52
   Google Scholar
• Lei SL, Xiao AT, Liu CX, Chen BP, Fang P, Dong CY. Comparison of infectivity of BTV-HbC3 to SPC-A-1 with that of BTV-10 prototype. Med J Wuhan Univ 2004; 25: 669–71
   Google Scholar
• Knowles BB, Howe CC, Aden DP. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science 1980; 209: 497–9
   PubMed Web of Science ®Google Scholar
• Du P. Medical experimental virology. People's Military Medical Press, Beijing 1985; 102–109
   Google Scholar
• Xue QS. Principles and techniques of culture in vitro. Beijing Science Publishing House, Beijing 2001
   Google Scholar
• Kikuchi H, Ujiie S, Wakui A, Yokoyama A, Kanamaru R. Features of DNA oligonucleosomal fragmentation in human tumor cell lines and its detection by flow cytometry: Utility and limitation. Jpn J Cancer Res 1997; 88: 56–65
   Google Scholar
• Poggioli GJ, Keefer JL, Connolly TS, Dermody TS, Tyler KL. Reovirus-induced G2/M cell cycle arrest requires σ1s and occurs in the absence of apoptosis. J Virol 2000; 74: 9562–70
   PubMed Web of Science ®Google Scholar
• McPhee DA, Parson IM, Della-Porta AJ. Comparative studies on the growth of Australian bluetongue virus serotypes in continuous cell lines and embryonated chicken eggs. Vet Microbiol 1982; 7: 401–10
   Google Scholar
• Norman KL, Lee PWK. Not all viruses are bad guys: The case for reovirus in cancer therapy. Drug Discov Today 2005; 10: 847–55
   PubMed Web of Science ®Google Scholar
• Wildner O. Comparison of replication-selective, oncolytic viruses for the treatment of human cancers. Curr Opin Mol Ther 2003; 5: 351–61
   PubMed Web of Science ®Google Scholar
• Vorburger SA, Pataer A, Swisher S, Gand Hunt KK. Genetically targeted cancer therapy: Tumor destruction by PKR activation. Am J Pharmacogenomics 2004; 4: 189–98
   PubMedGoogle Scholar
• Vidal L, Yap TA, White CL, Twigger K, Hingorani M, Agrawal V, et al. Reovirus and other oncolytic viruses for the targeted treatment of cancer. Target Oncol 2006; 1: 130–50
   Google Scholar
• Der SD, Zhou A, Williams B, Rand Silverman RH. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci USA 1998; 95: 15623–8
   PubMed Web of Science ®Google Scholar
• Strong JE, Coffey MC, Tang D, Sabinin D, Lee PWK. The molecular basis of viral oncolysis: Usurpation of the Ras signaling pathway by reovirus. EMBO 1998; 17: 3351–62
   PubMed Web of Science ®Google Scholar
• Norman KL, Kirasawa K, Yang AD, Shields MA, Lee PWK. Reovirus oncolysis: The Ras/RalGEF/p38 pathway dictates host cell permissiveness to reovirus infection. Proc Natl Acad Sci USA 2004; 101: 11099–104
   PubMed Web of Science ®Google Scholar
• Valenzuela DM, Groffen J. Four human carcinoma cell lines with novel mutations in position 12 of c-K-ras oncogene. Nucleic Acids Res 1986; 14: 843–52
   PubMedGoogle Scholar
• Rodgers SE, Barton ES, Oberhaus SM, Pike B, Gibson CA, Tyler KL, et al. Reovirus-induced apoptosis of MDCK cells is not linked to viral yield and is blocked by Bcl-2. J Virol 1997; 71: 2540–6
   PubMed Web of Science ®Google Scholar
• Mortola E, Noad R, Roy P. Bluetongue virus outer capsid proteins are sufficient to trigger apoptosis in mammalian cells. J Virol 2004; 78: 2875–83
   PubMed Web of Science ®Google Scholar
• Han ZY, Harty RN. The NS3 protein of Bluetongue virus exhibits viroporin-like properties. J Biol Chem 2004; 279: 43092–7
   Google Scholar